Job Opportunity: Production and IPQA Positions at Granules India Ltd
Company Overview:
Granules India is a leading pharmaceutical company, recognized for its vertical integration and remarkable growth over 38 years. Headquartered in Hyderabad, India, we specialize in producing high-quality Active Pharmaceutical Ingredients (API), Pharmaceutical Formulation Intermediates (PFI), and Finished Dosage (FD) products. Our commitment to manufacturing excellence, process innovation, and regulatory expertise has established us as a trusted partner to global pharmaceutical leaders.
Now Hiring Freshers for Production and IPQA Roles:
Production (Formulation OSD):
- Eligibility:
- ITI / B.Sc / Diploma (Pharmacy / Electrical / Mechanical / Chemical / Automobile)
- Age: 18-21 Years
- Graduated in 2022/23/24
- 50% aggregate in all academics
- Location: Granules India Ltd, Gagillapur Unit, Gandimaisamma, Hyderabad-500043
- Contact: 08418696400 / 08418696401
- Required Documents: Resume, photocopies of all educational certificates, Aadhaar Card & PAN
- Note: Candidates must be willing to work in shift operations. Spot offers will be provided to selected candidates upon document submission.
IPQA (In-Process Quality Assurance):
- Eligibility:
- B.Pharm Freshers
- Age: 18-22 Years
- Graduated in 2022/23/24
- 50% aggregate in all academics
- Location: Granules India Ltd, Gagillapur Unit, Gandimaisamma, Hyderabad-500043
- Contact: 08418696400 / 08418696401
- Required Documents: Resume, photocopies of all educational certificates, Aadhaar Card & PAN
- Note: Only male candidates preferred. Candidates must be willing to work in shift operations. Spot offers will be provided to selected candidates upon document submission.
Walk-In Interview Details:
- Date: 18th May 2024, Saturday
- Time: 10 am – 12 pm
- Location: Granules India Ltd, Gagillapur Unit, Gandimaisamma, Hyderabad-500043
![[Freshers] Granules India Hiring for Production – Formulation OSD / IPQA on 18th May 2024 [Freshers] Granules India Hiring for Production – Formulation OSD / IPQA on 18th May 2024](https://i0.wp.com/pharmabharat.com/wp-content/uploads/2024/05/GF18.webp?resize=724%2C1024&ssl=1)